Need professional-grade analysis? Visit stockanalysis.com
$12.56B
N/A
N/A
N/A
Regencell Bioscience Holdings Ltd (RGC) trades on United States in USD. The company is classified in the Healthcare sector under the Medicinal Chemicals & Botanical Products industry. The stock currently trades at $24.15, down 1.13% from the previous close.
Over the past year, RGC has traded between a low of $0.62 and a high of $78.00. The stock has gained 3475.1% over this period. It is currently 69.0% below its 52-week high.
Regencell Bioscience Holdings Ltd has a market capitalization of $12.56B.
Regencell Bioscience Holdings Ltd (RGC) is a biotechnology company focused on the research and development of regenerative medicine therapies. The company's main business is the development of stem cell-based treatments for various neurological and degenerative diseases. Regencell Bioscience is currently conducting clinical trials and collaborating with research institutions to advance its pipeline of innovative regenerative medicine solutions.